STOCK TITAN

RenovaCare Inc - RCAR STOCK NEWS

Welcome to our dedicated news page for RenovaCare (Ticker: RCAR), a resource for investors and traders seeking the latest updates and insights on RenovaCare.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RenovaCare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RenovaCare's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.52%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.32%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.43%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.43%
Tags
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.28%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.57%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.07%
Tags
conferences
RenovaCare Inc

OTC:RCAR

RCAR Rankings

RCAR Stock Data

8.73k
22.46M
Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Manufacturing
Link
United States
Scottsdale

About RCAR

renovacare, inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. our initial products under development target the body’s largest organ, the skin. our flagship technology, the cellmist™ system, uses our patented skingun™ to spray a liquid suspension of a patient’s stem cells – the cellmist™ solution – onto wounds. in investigative clinical use in the united states, skingun™ treatments have shown the potential to naturally and rapidly heal burns and other serious wounds. we are developing our cellmist™ system as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars. in the us alone, this $45 billion market is greater than spending on high-blood pressure management, cholesterol treatments, and back pain therapeutics.